The SCTC is an international consortium representing the vast majority of researchers and clinicians who have particular interest and expertise in the care of, and research in, scleroderma (systemic sclerosis). The SCTC aims to represent the views and interests of its membership regarding the performance of clinical research in scleroderma. The SCTC strongly encourages international collaboration, inclusiveness in research groups, and involvement of trainees and junior faculty in all its activities.